These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20216313)

  • 21. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).
    Rischin D; Peters L; Fisher R; Macann A; Denham J; Poulsen M; Jackson M; Kenny L; Penniment M; Corry J; Lamb D; McClure B
    J Clin Oncol; 2005 Jan; 23(1):79-87. PubMed ID: 15625362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current state-of-the-art for concurrent chemoradiation.
    Bernier J
    Semin Radiat Oncol; 2009 Jan; 19(1):3-10. PubMed ID: 19028339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
    Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
    Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y
    Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the management of squamous cell carcinoma of the head and neck.
    Kim KB; Khuri FR; Shin DM
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):99-110. PubMed ID: 12113140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
    Brizel DM; Esclamado R
    J Clin Oncol; 2006 Jun; 24(17):2612-7. PubMed ID: 16763273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
    Tannock I; Cummings B; Sorrenti V
    Cancer Treat Rep; 1982 Jun; 66(6):1421-4. PubMed ID: 6177413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent treatment modality for advanced head and neck carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1657-64. PubMed ID: 9757189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-of-the-art management of locally advanced head and neck cancer.
    Seiwert TY; Cohen EE
    Br J Cancer; 2005 Apr; 92(8):1341-8. PubMed ID: 15846296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination antiangiogenic therapy and radiation in head and neck cancers.
    Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
    Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy in head and neck cancer.
    Licitra L; Bergamini C; Mirabile A; Granata R
    Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):132-7. PubMed ID: 21372717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of targeted therapy for squamous cell carcinomas of the head and neck.
    Burgos-Tiburcio A; Santos ES; Arango BA; Raez LE
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):373-86. PubMed ID: 21417852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of experimental therapeutics for head and neck cancer.
    Lee J; Moon C
    Exp Biol Med (Maywood); 2011 Apr; 236(4):375-89. PubMed ID: 21427235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes.
    Ang KK
    Oncologist; 2008 Aug; 13(8):899-910. PubMed ID: 18701764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted therapy: A novel approach in head and neck cancer.
    Christy AW; Bojan A
    Indian J Dent Res; 2013; 24(2):261-6. PubMed ID: 23965459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.